In-San Kim is a KIST Fellow and professor at KU-KIST Graduate School of Converging Science and Technology, Korea University. He served as the president of several societies including KSBMB. Kim’s research focuses on extracellular matrix proteins and cell adhesion molecules and their roles in cancer. He identified stabilin proteins as a phosphatidylserine receptor crucial for clearing apoptotic cells and has expanded his interests to develop nanocage protein and exosome-based drugs that harness the immune system for cancer control. Kim has published 320+ papers and received awards, including Hyeoksin Medal for Science and Technology Merit from the Korean Government in 2022. He founded ShiftBio Inc., a startup company that develops exosome-based therapeutics.